Renovion
Interview with the Lung Transplant Foundation: Participating in a Lung Transplant Clinical Trial
Carolyn Durham, CSO at Renovion and Amy S., ED at the LTx Foundation discuss real-world experience of being in a clinical trial in LTx.
top of page
News
Search
Renovion
Apr 18, 20232 min read
First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung Transplant
Source | Business Wire April 18, 2023 08:52 AM Eastern Daylight Time CHAPEL HILL, N.C - Renovion, Inc. today announced that the first...
Renovion
Mar 30, 20232 min read
Renovion Receives FDA Fast Track Designation for ARINA-1 for the Prevention of BOS Progression in LT
The Fast Track designation accelerates the FDA regulatory path for ARINA-1 for the prevention of bronchiolitis obliterans syndrome (BOS)...
Renovion
Aug 2, 20222 min read
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for serious chronic inflammatory lung diseases...
Renovion
Jan 6, 20172 min read
Renovion Receives Orphan Designation for ARINA-1 for the treatment of Lung Dysfunction
Renovion, Inc. ("Renovion"), an early stage drug development company targeting the treatment of lung transplant and other chronic...
bottom of page